No Detail Found!

Myelofibrosis in Patients of Chronic Myeloid Leukemia in Chronic Phase at Presentation.

Author(s)
Ambareen Hamid Department of Pathology King Edward Medical University (KEMU), Lahore, Pakistan
Sobia Ashraf Department of Pathology King Edward Medical University (KEMU), Lahore, Pakistan
Samina Qamar Department of Pathology King Edward Medical University (KEMU), Lahore, Pakistan
Muhammad Asif Naveed Department of Pathology King Edward Medical University (KEMU), Lahore, Pakistan
Ahmad Hameed Department of Pathology King Edward Medical University (KEMU), Lahore, Pakistan
Muhammad Azhar Farooq Paediatric Medicine King Edward Medical University (KEMU), Lahore, Pakistan
Abstract
Objective: To determine the frequency and grading of myelofibrosis in patients of chronic myeloid leukaemia in chronic phase, and the association of cytopenias/cytosis with the degree of fibrosis. Study Design: Descriptive study. Place and Duration of Study: King Edward Medical University, Lahore, from March 2015 to April 2017. Methodology: Patients of both genders and all age groups with Philadelphia chromosome/BCR-ABL positivity were included in the study. Detailed medical history and examination findings were recorded. Sample for CBC was taken in EDTA and run on automated haematology analyser. Bone marrow aspirate and trephine biopsy was done from posterior iliac crest. Bone marrow aspirate slides were stained with Giemsa stain. The trephine biopsy was processed and stained with haematoxilyn and eosin. Silver (reticulin) and trichrome staining was done on trephine biopsy to assess the degree of fibrosis. Grading of fibrosis was done according to WHO revised classification 2016. Results: Among the 82 cases, 65% (n=53) were having WHO Grade MF 1 myelofibrosis, 27% (n=22) WHO Grade MF 2 myelofibrosis; whereas, 08% (n=07) WHO Grade MF 3 myelofibrosis. CBC counts were analysed to see any association between anemia, thrombocytocytosis and leucocytosis with advanced fibrosis (p=0.148, 0.413 and 0.174, respectively). Conclusion: Some degree of bone marrow fibrosis was present in all patients of chronic myeloid leukemia, while advance fibrosis (WHO Grade MF 2 and 3) is also common. Peripheral blood counts are not predictor of increased fibrosis. Therefore, bone marrow biopsy with special staining should be done in all cases of chronic phase of CML.
Publication Details
Page(s) 1096-1100
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 11, Year: 2019

Request the full text from PASTIC

Keywords
Anemia, Leucocytosis, Cytopenia, hemotoxylin, Special staining, Chronic myeloid leukemia, Cytosis eosin, Blood counts, Thrombocytosis, Myelofibrosis, WHO revised classification 2016
0

Citations

0

Downloads

58

Views